Grandeur Peak Global Advisors’s Medpace MEDP Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $5.85M | Buy |
18,626
+338
| +2% | +$106K | 0.7% | 42 |
|
2025
Q1 | $5.57M | Sell |
18,288
-9,977
| -35% | -$3.04M | 0.62% | 42 |
|
2024
Q4 | $9.39M | Buy |
28,265
+165
| +0.6% | +$54.8K | 0.83% | 31 |
|
2024
Q3 | $9.38M | Buy |
28,100
+6,849
| +32% | +$2.29M | 0.78% | 38 |
|
2024
Q2 | $8.75M | Sell |
21,251
-7,260
| -25% | -$2.99M | 0.7% | 44 |
|
2024
Q1 | $11.5M | Sell |
28,511
-8,613
| -23% | -$3.48M | 0.92% | 32 |
|
2023
Q4 | $11.4M | Sell |
37,124
-8,024
| -18% | -$2.46M | 0.8% | 28 |
|
2023
Q3 | $10.9M | Sell |
45,148
-44,358
| -50% | -$10.7M | 0.82% | 24 |
|
2023
Q2 | $21.5M | Buy |
89,506
+1,260
| +1% | +$303K | 1.47% | 17 |
|
2023
Q1 | $16.6M | Buy |
88,246
+3,345
| +4% | +$629K | 1.01% | 24 |
|
2022
Q4 | $18M | Sell |
84,901
-63,215
| -43% | -$13.4M | 1.07% | 24 |
|
2022
Q3 | $23.3M | Buy |
148,116
+5,441
| +4% | +$855K | 1.43% | 19 |
|
2022
Q2 | $21.4M | Buy |
142,675
+20,879
| +17% | +$3.12M | 1.33% | 21 |
|
2022
Q1 | $19.9M | Buy |
121,796
+86,258
| +243% | +$14.1M | 0.94% | 26 |
|
2021
Q4 | $7.73M | Sell |
35,538
-1,529
| -4% | -$333K | 0.35% | 52 |
|
2021
Q3 | $7.02M | Buy |
37,067
+2,000
| +6% | +$379K | 0.33% | 53 |
|
2021
Q2 | $6.19M | Buy |
35,067
+2,700
| +8% | +$477K | 0.3% | 59 |
|
2021
Q1 | $5.31M | Buy |
32,367
+3,100
| +11% | +$509K | 0.29% | 54 |
|
2020
Q4 | $4.07M | Buy |
29,267
+10,300
| +54% | +$1.43M | 0.23% | 60 |
|
2020
Q3 | $2.12M | Buy |
18,967
+1,817
| +11% | +$203K | 0.14% | 77 |
|
2020
Q2 | $1.6M | Buy |
17,150
+14,200
| +481% | +$1.32M | 0.12% | 79 |
|
2020
Q1 | $216K | Buy |
+2,950
| New | +$216K | 0.02% | 106 |
|